Antibody Therapeutics Purification
Source: Thermo Fisher Scientific
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
Antibody purification by affinity chromatography
CaptureSelect affinity chromatography resins, specifically developed to bind antibody-subdomain regions are a key solution for the purification of novel antibody therapeutics, such as bi-specific monoclonal antibodies, Fab fragments, and Fc-fusion proteins. These resins are based on the CaptureSelect technology, enabling increased purity and yield in a single purification step.
This website uses cookies to ensure you get the best experience on our website. Learn more